Skip to main content
Premium Trial:

Request an Annual Quote

Genaco Biomedical Wins $99,000 SBIR Grant to Develop Bead-Based microRNA Expression Profiling Technology

NEW YORK, June 17 (GenomeWeb News) - Genaco Biomedical Products of Huntsville, Ala., has received a six-month Small Business Innovation Research grant worth $99,000 from the National Cancer Institute to develop a bead-based array system for the detection of microRNAs, according to NIH databases.

 

The company has already developed a method based on Luminex's xMAP platform that uses locked nucleic acid technology, according to the grant abstract. Genaco intends to use the system to develop an assay based on 20 cancer-related miRNA targets and to use this prototype assay to study cancer samples.

 

For more information, see an article in this week's RNAi News.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.